End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | -.--% | -.--% |
2023 | Octopus Biosafety SA Auditor Raises 'Going Concern' Doubt | CI |
2023 | Octopus Biosafety SA Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|
Capitalization 1 | 1.723 | 5.839 | 3.19 | 1.696 |
Enterprise Value (EV) 1 | 2.295 | 5.613 | 4.835 | 4.335 |
P/E ratio | - | -7.02 x | -3.16 x | -2.11 x |
Yield | - | - | - | - |
Capitalization / Revenue | 133 x | 8.82 x | 5.94 x | 6.11 x |
EV / Revenue | 177 x | 8.48 x | 9 x | 15.6 x |
EV / EBITDA | -1.49 x | -6.07 x | -7.94 x | -9.09 x |
EV / FCF | - | - | - | - |
FCF Yield | - | - | - | - |
Price to Book | - | 15.6 x | -5.02 x | -1.18 x |
Nbr of stocks (in thousands) | 2,027 | 4,055 | 4,058 | 4,058 |
Reference price 2 | 0.8500 | 1.440 | 0.7860 | 0.4180 |
Announcement Date | 6/14/21 | 6/14/21 | 6/8/22 | 6/8/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|
Net sales 1 | 0.0129 | 0.6617 | 0.5369 | 0.2775 |
EBITDA 1 | -1.539 | -0.9241 | -0.6088 | -0.477 |
EBIT 1 | -2.021 | -1.401 | -1.12 | -0.7259 |
Operating Margin | -15,614.61% | -211.76% | -208.59% | -261.62% |
Earnings before Tax (EBT) 1 | -1.658 | -1.062 | -1.257 | -0.9595 |
Net income 1 | -1.406 | -0.832 | -1.011 | -0.8027 |
Net margin | -10,868.28% | -125.74% | -188.21% | -289.29% |
EPS | - | -0.2050 | -0.2490 | -0.1978 |
Free Cash Flow | - | - | - | - |
FCF margin | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - |
Dividend per Share | - | - | - | - |
Announcement Date | 6/14/21 | 6/14/21 | 6/8/22 | 6/8/23 |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|
Net Debt 1 | 0.57 | - | 1.65 | 2.64 |
Net Cash position 1 | - | 0.23 | - | - |
Leverage (Debt/EBITDA) | -0.3715 x | - | -2.702 x | -5.532 x |
Free Cash Flow | - | - | - | - |
ROE (net income / shareholders' equity) | - | 614% | 774% | 77.4% |
ROA (Net income/ Total Assets) | - | -52.4% | -35.7% | -27.2% |
Assets 1 | - | 1.586 | 2.831 | 2.946 |
Book Value Per Share | - | 0.0900 | -0.1600 | -0.3500 |
Cash Flow per Share | - | 0.1700 | 0.0200 | 0.0100 |
Capex | - | - | - | - |
Capex / Sales | - | - | - | - |
Announcement Date | 6/14/21 | 6/14/21 | 6/8/22 | 6/8/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- MLOCT Stock
- Stock
- Financials Octopus Robots